Successfully Treated Case of Cholangiolocellular Carcinoma with a Poor Hepatic Functional Reserve Reporting with Various Imaging Findings
Cholangiolocellular carcinoma (CoCC) is a rare primary liver cancer that is difficult diagnose due to a lack of specific imaging findings. We herein report a case of CoCC accompanied by severe alcoholic cirrhosis. Dynamic computed tomography showed a low-density tumor with a faint surrounding enhancement. Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging revealed iso-intensity in the hepatobiliary phase and a maximum tumor diameter of 53 mm. 18F-fluoro-2-deoxyglucose position-emission tomography was moderately positive (maximum standardized uptake value: 4.3). CoCC was diagnosed based on the pathological findings, including immunohistochemistry. We discuss the diagnostic imaging findings and review previous reports.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
|---|---|
| Enthalten in: |
Internal medicine (Tokyo, Japan) - 60(2021), 6 vom: 15. März, Seite 873-881 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Takakusagi, Satoshi [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Case Reports |
|---|
| Anmerkungen: |
Date Completed 14.04.2021 Date Revised 16.04.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.2169/internalmedicine.5891-20 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM316250864 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM316250864 | ||
| 003 | DE-627 | ||
| 005 | 20231225160701.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2169/internalmedicine.5891-20 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1054.xml |
| 035 | |a (DE-627)NLM316250864 | ||
| 035 | |a (NLM)33055484 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Takakusagi, Satoshi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Successfully Treated Case of Cholangiolocellular Carcinoma with a Poor Hepatic Functional Reserve Reporting with Various Imaging Findings |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.04.2021 | ||
| 500 | |a Date Revised 16.04.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Cholangiolocellular carcinoma (CoCC) is a rare primary liver cancer that is difficult diagnose due to a lack of specific imaging findings. We herein report a case of CoCC accompanied by severe alcoholic cirrhosis. Dynamic computed tomography showed a low-density tumor with a faint surrounding enhancement. Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging revealed iso-intensity in the hepatobiliary phase and a maximum tumor diameter of 53 mm. 18F-fluoro-2-deoxyglucose position-emission tomography was moderately positive (maximum standardized uptake value: 4.3). CoCC was diagnosed based on the pathological findings, including immunohistochemistry. We discuss the diagnostic imaging findings and review previous reports | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a EMA | |
| 650 | 4 | |a FDG-PET | |
| 650 | 4 | |a cholangiolocellular carcinoma | |
| 650 | 4 | |a immunohistochemistry | |
| 650 | 4 | |a liver cirrhosis | |
| 650 | 4 | |a needle biopsy | |
| 650 | 7 | |a Contrast Media |2 NLM | |
| 700 | 1 | |a Yokoyama, Yozo |e verfasserin |4 aut | |
| 700 | 1 | |a Kizawa, Kazuko |e verfasserin |4 aut | |
| 700 | 1 | |a Marubashi, Kyoko |e verfasserin |4 aut | |
| 700 | 1 | |a Kosone, Takashi |e verfasserin |4 aut | |
| 700 | 1 | |a Sato, Ken |e verfasserin |4 aut | |
| 700 | 1 | |a Kakizaki, Satoru |e verfasserin |4 aut | |
| 700 | 1 | |a Harada, Kenichi |e verfasserin |4 aut | |
| 700 | 1 | |a Takagi, Hitoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Uraoka, Toshio |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Internal medicine (Tokyo, Japan) |d 1996 |g 60(2021), 6 vom: 15. März, Seite 873-881 |w (DE-627)NLM012606731 |x 1349-7235 |7 nnns |
| 773 | 1 | 8 | |g volume:60 |g year:2021 |g number:6 |g day:15 |g month:03 |g pages:873-881 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2169/internalmedicine.5891-20 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 60 |j 2021 |e 6 |b 15 |c 03 |h 873-881 | ||